Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Natus Medical : Natus to Present at the Thomas Weisel Partners 2007 Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/28/2007 | 02:00pm CEST

Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Thomas Weisel Partners 2007 Healthcare Conference. The conference is being held at the Four Seasons Hotel in Boston, Massachusetts. Mr. Murphy is scheduled to present at 2:05 p.m. Eastern Time (11:05 a.m. PT) on Thursday, September 6, 2007.

Investors may listen to the live webcast and view a copy of the slide presentation online via the ?Investors? section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days. Attendance at the Thomas Weisel Partners 2007 Healthcare Conference is by invitation only.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, Chief Financial Officer, 650-802-0400
[email protected]


© Business Wire 2007
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
10/11 Natus Medical to Hold 2017 Third Quarter Financial Results Conference Call on..
10/09 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Completion of Acquisitio..
10/07 NATUS MEDICAL : Nordea Investment Management AB Raises Holdings in Natus Medical..
10/06 NATUS MEDICAL INC : Completion of Acquisition or Disposition of Assets, Financia..
10/06 Natus Completes Acquisition of Neurosurgery Assets from Integra LifeSciences
09/12 NATUS MEDICAL : to Acquire Neurosurgery Assets from Integra LifeSciences, Enters..
09/11 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Entry into a Material De..
09/11 NATUS MEDICAL INC : Entry into a Material Definitive Agreement, Financial Statem..
09/11 Natus to Acquire Neurosurgery Assets from Integra LifeSciences, Enters Neuros..
09/02 NATUS MEDICAL : $34,729 Federal Contract Awarded to Natus Medical
More news
News from SeekingAlpha
10/06 Natus completes acquisition of neurosurgery assets from Integra
09/11 Natus Medical to buy neurosurgery assets from Integra for $47.5M; shares ahea..
07/26 Natus Medical's (BABY) CEO James Hawkins on Q2 2017 Results - Earnings Call T..
07/26 Natus Medical Q2 revenues up 27%; updates guidance
07/26 Natus Medical beats by $0.01, beats on revenue
Financials ($)
Sales 2017 505 M
EBIT 2017 76,0 M
Net income 2017 22,4 M
Debt 2017 37 027 M
Yield 2017 -
P/E ratio 2017 59,11
P/E ratio 2018 25,99
Capi. / Sales 2017 75,9x
Capi. / Sales 2018 2,60x
Capitalization 1 323 M
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 49,5 $
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer & Executive Vice President
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC13.94%1 314
THERMO FISHER SCIENTIFIC INC.34.10%75 478
DANAHER10.55%59 778
BOSTON SCIENTIFIC CORPORATION36.48%40 505
INTUITIVE SURGICAL67.64%39 496
ROYAL PHILIPS20.29%38 649